Keywords: fda, review, tykerb, breast, cancer, therapy, uk

FDA to review Tykerb as breast cancer therapy

Article | 25 September 2006

Print This

UK drug major GlaxoSmithKline says it has submitted a New Drug Application to the US Food and Drug Administration requesting ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in